Moreover, we observed a correlation with ATGL protein levels and grade of steatosis (Fig. 7g), suggesting that this pathway is altered in NAFLD and might contribute to the progression of this disease. The gene discussed is PNPLA2; the disease is metabolic dysfunction-associated steatotic liver disease.